Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-27
1991-07-16
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546286, A61K 3144, C07D21178
Patent
active
050326015
ABSTRACT:
Dihydropyridine compounds of the formula ##STR1## in which R.sup.1 is a nitrophenyl group and R.sup.2, R.sup.3, and R.sup.4 are lower alkyl groups or pharmaceutically acceptable salts thereof are useful for improving venous extensibility and suppressing cardiac hypertrophy.
REFERENCES:
patent: 4284634 (1981-08-01), Sato
patent: 4338322 (1982-07-01), Sato
patent: 4782070 (1988-11-01), Ono et al.
Ono Takaharu
Otsuka Minoru
Fujisawa Pharmaceutical Company, Ltd.
Waddell Frederick E.
LandOfFree
Venous extensibility improving and cardiac hypertrophy suppressa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Venous extensibility improving and cardiac hypertrophy suppressa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Venous extensibility improving and cardiac hypertrophy suppressa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-132079